1 Introduction {#SEC1}
==============

The recently described ribosome footprinting technology ([@btw585-B4]) allows the identification of mRNA fragments that were protected by the ribosome. It provides valuable information on ribosome occupancy and, thereby indirectly, on protein synthesis activity. This technology can be leveraged by combining the measurements from RNA-Seq estimates in order to determine a gene's translation efficiency (TE), which is the ratio of the abundances of translated mRNA and available mRNA ([@btw585-B3]). The normalization by mRNA abundance is designed to remove transcriptional activity as a confounder of RF abundance. The TEs in treatment/control experiments can then be compared to identify genes most affected w.r.t. translation efficiency. For instance, [@btw585-B9] considered a ratio (fold-change) of the TEs of treatment and control. However, what these initial approaches only take into account partially is that one typically only obtains uncertain estimates of the mRNA and ribosome abundance. In particular for lowly expressed genes, the error bars for the ratio of two TE values can be large. As in proper RNA-Seq analyses, one should consider the uncertainty in these abundance measurements when testing for differential abundance. For RNA-Seq, this has been described in various ways often based on generalized linear models taking advantage of dispersion information from biological replicates ([@btw585-B1]; [@btw585-B2]; [@btw585-B7]). In [@btw585-B10] and [@btw585-B11], a way to adopt an approach for RNA-Seq analysis for this problem was described that had several conceptual and practical limitations. Here, we describe a novel statistical framework that also uses a generalized linear model to detect effects of a particular treatment on mRNA translation. Additionally, our approach accounts for the fact that two different sequencing protocols with distinct statistical characteristics are used. We compare it to the *Z*-score based approach ([@btw585-B9]), DESeq2 ([@btw585-B5]) and a recently published tool Babel ([@btw585-B6]) that is based on errors-in-variables regression. Shell and Python scripts for trimming RF adaptor, aligning reads, removing rRNA contamination and counting reads are also included in the RiboDiff package.

2 Methods {#SEC2}
=========

In sequencing-based ribosome footprinting, the RF read count is naturally confounded by mRNA abundance ([Fig. 1A](#btw585-F1){ref-type="fig"}). We seek a strategy to compare RF measurements taking mRNA abundance into account in order to accurately discern the translation effect in case--control experiments. We model the vector of RNA-Seq and RF read counts $y_{\text{mRNA}}^{i}$ and $y_{\text{RF}}^{i}$, respectively, for gene *i* with Negative Binomial (NB) distributions, as described before (for instance, [@btw585-B5]; [@btw585-B2]; [@btw585-B7]): $y^{i}\, \sim \, NB(\mu^{i},\kappa^{i}),$ where μ^*i*^ is the expected count and κ^*i*^ is the estimated dispersion across biological replicates. Here *y^i^* denotes the observed counts normalized by the library size factor ([Supplementary Section A](#sup1){ref-type="supplementary-material"}). Formulating the problem as a generalized linear model (GLM) with the logarithm as link function, we can express expectations on read counts as a function of latent quantities related to *mRNA abundance* β~*C*~ in the two conditions ($C = \left\{ 0,1 \right\}$), a quantity $\beta_{\text{RNA}}$ that relates mRNA abundance to RNA-Seq read counts, a quantity $\beta_{\text{RF}}$ that relates mRNA abundance to RF read counts and a quantity $\beta_{\Delta,C}$ that captures the effect of the treatment on translation. In particular, the expected RNA-Seq read count $\mu_{\text{mRNA},C}^{i}$ is given by the equation $\text{log}(\mu_{\text{mRNA},C}^{i}) = \beta_{C}^{i} + \beta_{\text{RNA}}^{i}$.

![(**A**) Graphical model representing RidoDiff (Gray circle: observable variables; empty circle: unobservable variables; black square: functions; *r* denotes biological replicates; *i* denotes a gene and *G* is the number of genes). The dashed line denotes the relationship that we aim to test (see Methods for details). (**B**) Receiver operating characteristic (ROC) curve of RiboDiff (with separate dispersions), edgeR and DESeq2 (with interaction model), Z-score method and Babel on simulated data with large difference between dispersions of RF and RNA-Seq counts (see also [Supplementary Fig. S-4](#sup1){ref-type="supplementary-material"}). (**C**) Comparison of the distribution of TE ratios of genes that were detected to have a significant change in translation efficiency by RiboDiff (w/joint dispersion), *Z*-score based analysis and Babel. DESeq2 was very similar to RiboDiff (w/joint dispersion) and was omitted. Data was taken from GEO accession GSE56887 (Color version of this figure is available at *Bioinformatics* online.)](btw585f1p){#btw585-F1}

We assume that transcription and translation are successive cellular processing steps and that abundances are linearly related. The expected RF read count, $\mu_{\text{RF},C}^{i}$, is given by $\text{log}(\mu_{\text{RF},C}^{i}) = \beta_{C}^{i} + \beta_{RF}^{i} + \beta_{\Delta,C}^{i}$. A key point to note is that $\beta_{C}^{i}$ is revealed to be a shared parameter between the expressions governing the expected RNA-Seq and RF counts. It can be considered to be a proxy for shared transcriptional/translation activity under condition *C* in this context. Then, $\beta_{\Delta,C}^{i}$ indicates the deviation from that activity under condition *C*, with $\beta_{\Delta,C}^{i} = 0$ for *C* = 0 and free otherwise (See [Supplementary Section B](#sup1){ref-type="supplementary-material"} for more details).

Fitting the GLM consists of learning the parameters β^*i*^ and dispersions κ^*i*^ given mRNA and RF counts for the two conditions $C = \left\{ 0,1 \right\}$. We perform alternating optimization of the parameters β^*i*^ given dispersions κ^*i*^ and the dispersion parameters κ^*i*^ given β^*i*^, similar to the EM algorithm ([Supplementary Sections B and C](#sup1){ref-type="supplementary-material"}): $$\left. \beta^{i} = \underset{\beta^{i}}{\text{arg}\,\text{max}}\ell_{glm}(\beta^{i} \middle| y^{i},\kappa^{i})\quad\text{and}\quad\kappa^{i} = \underset{\kappa^{i}}{\text{arg}\,\text{max}}\ell_{NB}(\kappa^{i} \middle| y^{i},\mu^{i}). \right.$$ As experimental procedures for measuring mRNA counts and RF counts differ, we enable the estimating of separate dispersion parameters for the data sources of RNA-Seq and RF profiling to account for different characteristics ([Supplementary Section E](#sup1){ref-type="supplementary-material"}).

As in [@btw585-B1], with raw dispersions estimated from previous steps, we regress all κ^*i*^ given the mean counts to obtain a mean-dispersion relationship $f(\mu) = \lambda_{1}/\mu + \lambda_{0}$. We perform empirical Bayes shrinkage ([@btw585-B5]) to shrink κ^*i*^ towards $f(\mu)$ to stabilize estimates (see [Supplementary Section D](#sup1){ref-type="supplementary-material"}). The proposed model in RiboDiff with a joint dispersion estimate is conceptually identical to using the following GLM design matrix $\text{protocol} + \text{condition} + \text{condition}:\text{protocol}$ (for instance, in conjunction with edgeR or DESeq1/2).

In a treatment/control setting, we can then evaluate whether a treatment (*C* = 1) has a significant differential effect on translation efficiency compared to the control (*C* = 0). This is equivalent to determining whether the parameter $\beta_{\Delta,1}$ differs significantly from 0 and whether the relationship denoted by the dashed arrow in [Figure 1A](#btw585-F1){ref-type="fig"} is needed or not. We can compute significance levels based on the $\chi^{2}$ distribution by analyzing $\text{log}$-likelihood ratios of the Null model ($\beta_{\Delta,1}^{i} = 0$) and the alternative model ($\beta_{\Delta,1}^{i} = 0$).

3 Results and discussion {#SEC3}
========================

We simulated data with different dispersions applied to mRNA and RF counts (see [Supplementary Section F](#sup1){ref-type="supplementary-material"}). We illustrate the performance of our method RiboDiff (with separate dispersion estimates) as well as Babel and the *Z*-score method. Although conceptually closely related to RiboDiff with joint dispersion estimates, we also include DESeq2 and edgeR with a GLM that includes an interaction term (GLM $\text{condition} + \text{protocol} + \text{condition}:\text{protocol}$) to model RNA-seq and RF counts. [Figure 1B](#btw585-F1){ref-type="fig"} shows the receiver operating characteristic (ROC) curve for a case with large dispersion differences between RF and RNA-seq counts. RiboDiff exhibits a superior detection accuracy compared to edgeR, DESeq2, Babel and *Z*-score method, which is less pronounced when RF and RNA-Seq dispersions are more similar (see [Supplementary Fig. S-4](#sup1){ref-type="supplementary-material"}). We obtained close to identical results for RiboDiff with joint dispersion and DESeq2 with interaction term, although edgeR with the same setting is slightly better than RiboDiff with joint dispersion (data not shown). Our experiments illustrate that it can be beneficial to use the RiboDiff model with separate dispersions, in particular, when the dispersions of RF and RNA-seq data differ considerably.

We also re-analyzed previously released ribosome footprint data (GEO accession GSE56887). After multiple testing correction, RiboDiff detected 601 TE down-regulated genes and 541 up-regulated ones with FDR $\leq$ 0.05, which is about twice as many as reported previously. The new significant TE change set includes more than 90% genes identified in the previous study. RiboDiff is also compared to *Z*-score method and we find major differences (see [Fig. 1C](#btw585-F1){ref-type="fig"}). [Supplementary Section G](#sup1){ref-type="supplementary-material"} provides the evidences showing that the *Z*-score based method is biased towards genes with low read count, whereas RiboDiff identifies more plausible differences. Babel identifies only very few genes with differential TE. We ran the differential test of RiboDiff on a machine with 1.7 GHz CPU and 4 GB RAM, it took 23 min of computing time to finish (10 474 genes having both mRNA and RF counts).

In summary, we propose a novel statistical model to analyze the effect of the treatment on mRNA translation and to identify genes of differential translation efficiency. A major advantage of this method is facilitating comparisons of RF abundance by taking mRNA abundance variability as a confounding factor. Moreover, RiboDiff is specifically tailored to produce robust dispersion estimates for different sequencing protocols measuring gene expression and ribosome occupancy that have different statistical properties. The described approach is statistically sound and identifies a similar set of genes from a less developed method that was used in recent work [@btw585-B10]. The release of this tool is expected to enable proper analyses of data from many future RF profiling experiments (e.g. [@btw585-B8]). The described model assumes that RNA-seq and RF samples are unpaired and it is future work to extend the flexibility of the tool to a broader range of experimental settings.
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